Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010832-17Phase 4Active
Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Ivabradine with Placebo (2 arms). Primary endpoints: High-sensitivity C-reactive protein, Soluble CD40 ligand and 4 more. Started Apr 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010832-17.